✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Shukra Pharmaceuticals Ltd.

SHUKRAPHAR

Market Cap
₹754 Cr.
P/E
92.22

Shukra Pharmaceuticals Ltd.

  • Shukra Pharma
  • Kwality Pharma
  • NGL Fine-Chem
FAQs on Shukra Pharmaceuticals Ltd. Shareprice

Shukra Pharma has given better returns compared to its competitors.
Shukra Pharma has grown at ~180.73% over the last 2yrs while peers have grown at a median rate of 43.17%

Yes, Shukra Pharma is expensive.
Latest PE of Shukra Pharma is 92.22, while 3 year average PE is 67.73.
Also latest EV/EBITDA of Shukra Pharma is 75.03 while 3yr average is 24.33.

View FAQ's On Business
Growth Table
  • Shukra Pharmaceuticals Ltd.
  • Kwality Pharma
  • NGL Fine-Chem
Balance Sheet
  • Shukra Pharmaceuticals Ltd.
  • Kwality Pharma
  • NGL Fine-Chem
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Shukra Pharmaceuticals Ltd.
  • Kwality Pharma
  • NGL Fine-Chem
Cash Flow
  • Shukra Pharmaceuticals Ltd.
  • Kwality Pharma
  • NGL Fine-Chem
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Shukra Pharmaceuticals Ltd.
  • Kwality Pharma
  • NGL Fine-Chem
Quarterly Results
  • Shukra Pharmaceuticals Ltd.
  • Kwality Pharma
  • NGL Fine-Chem
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Shukra Pharmaceuticals Ltd. Financials

Balance sheet of Shukra Pharma is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Shukra Pharma is increasing.
Latest debt of Shukra Pharma is -₹15.31 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹16.64 Crs.

The profit is oscillating.
The profit of Shukra Pharma is ₹8.18 Crs for TTM, ₹18.54 Crs for Mar 2024 and ₹4.41 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Shukra Pharma latest dividend payout ratio is 5.9% and 3yr average dividend payout ratio is 6.92%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech